Literature Review
All posts tagged with “Clinical News | Pharmacy & Medication News | Psilocybin News.”
Laws in motion to bring ‘Right to Try’ psychedelics at end-of-life
05/27/24 at 03:00 AMLaws in motion to bring ‘Right to Try’ psychedelics at end-of-life Hospice News; by Holly Vossel; 5/21/24Hospice providers are navigating an evolving landscape of laws opening up pathways of access around psychedelic utilization at the end of life. Despite mounting evidence that psychedelics can improve experiences and reduce symptom burden in some terminally ill patients, these drugs remain difficult to access for those wishing to utilize them. Some states and the federal government have considered legislation that would establish a “right to try” psychedelics and other experimental interventions for certain seriously ill patients.
Top ten tips palliative care clinicians should know about the psychiatric manifestations of nonpsychiatric serious illness and treatments
05/13/24 at 03:00 AMTop ten tips palliative care clinicians should know about the psychiatric manifestations of nonpsychiatric serious illness and treatments Journal of Palliative Medicine; by Gregg A Robbins-Welty, Paul A Riordan, Daniel Shalev, Danielle Chammas, Paul Noufi, Keri O Brenner, Joshua Briscoe, William E Rosa, Jason A Webb; 5/10/24... Among patients receiving palliative care (PC), psychiatric comorbidities are common and impact patient quality of life. ... This article, created collaboratively with a team of psychiatric-palliative care experts, is the second in a two-part series examining the bidirectional relationship between medical and psychiatric illness in PC. This article explores 10 prevalent psychiatric manifestations associated with severe illness and its treatment. [Additional access requires journal subscription or additional payment]
DEA tells court that Right to Try law doesn’t supersede CSA in psilocybin case
05/02/24 at 03:00 AMDEA tells court that Right to Try law doesn’t supersede CSA in psilocybin case PsychedelicNewsWire; 4/30/24The U.S. Drug Enforcement Administration (DEA) is claiming that a federal law that affords severely ill individuals the right to try investigational medications doesn’t apply to drugs classified under the Controlled Substances Act. This is in response to a lawsuit filed by a doctor in Washington state who sought permission to legally administer psilocybin as treatment for patients in end-of-life care with cancer. The agency argues that because drugs classified under Schedule I are said to have no accepted medical use, the law prevents them from being dispensed, even by professionals.
Palliative care’s psychedelic future
02/16/24 at 03:00 AMPalliative care’s psychedelic futuretruthdig, by Jane C. Hu; 2/14/24In Oregon, hospice doctors are expanding the menu of treatments for end-of-life anxiety and depression.
Debate over psychedelic therapy returns to Missouri General Assembly
02/06/24 at 04:00 AMDebate over psychedelic therapy returns to Missouri General AssemblyMissouri Independent, by Rebecca Rivas; 1/30/24Republican lawmakers are once again pushing legislation that would require Missouri to conduct a clinical study on using psilocybin, more commonly referred to as “magic mushrooms,” to treat depression, substance use or as part end-of-life care.
Psychedelic therapy debate returns to Missouri General Assembly
02/01/24 at 03:15 AMPsychedelic therapy debate returns to Missouri General AssemblyMissouri Independent, by Rebecca Rivas; 1/30/24Numerous clinical studies nationwide have shown positive results from using psilocybin to treat PTSD, depressiona and substance use. Republican lawmakers are once again pushing legislation that would require Missouri to conduct a clinical study on using psilocybin, more commonly referred to as “magic mushrooms,” to treat depression, substance use or as part end-of-life care. ... In the House Veterans Committee on Tuesday, Republican Rep. Aaron McMullen of Independence plans to present an amended version of the bill that would limit its scope to only veterans. The suicide rate among veterans in Missouri is nearly double the state rate and one of the highest in the country. ... McMullen, a veteran who served in a combat unit in Afghanistan, told The Independent, “While psilocybin is not a panacea for every issue, it represents a first true scientifically-validated hope that we have to address this crisis.”
New data sheds light on how many people are taking psilocybin in Oregon
12/16/23 at 03:57 AMNew data sheds light on how many people are taking psilocybin in OregonPortland (OR) Business JournalDecember 14, 2023About 600 people have completed psilocybin sessions since Oregon’s program rolled out earlier this year, according to the Healing Advocacy Fund, a nonprofit organization that closely tracks psilocybin legislation and research. At least that many clients have taken psychedelic mushrooms since the first service center opened in May.
CT to consider decriminalization of psychedelic mushrooms. What you should know.
12/12/23 at 03:34 AMCT to consider decriminalization of psychedelic mushrooms. What you should know.Hartford CourantDecember 10, 2023... In the same way that marijuana was considered for decades as an illegal drug, a societal shift allowed a refocus on medical marijuana for pain relief and other uses. Now, mushrooms are also being viewed for their potential benefits though some politicians still remain skeptical. The next step is that advocates want to decriminalize possession of small amounts of mushrooms, and they will be pushing for that in the 2024 legislative session. The state House of Representatives passed a bill last year, but the issue was never debated in the Senate before time ran out. Now, in a short session that starts in early February, advocates are taking another chance at decriminalization.
Oregon’s legal psilocybin clinics draw hundreds—mostly from out of state
12/01/23 at 04:00 AMOregon’s legal psilocybin clinics draw hundreds—mostly from out of state
Lawmakers put off consideration of psilocybin bill until new year
12/01/23 at 04:00 AMLawmakers put off consideration of psilocybin bill until new year